Prosecution Insights
Prosecution Insights
5 pending office actions • 2 clients • 4 examiners • 3 art units • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (80%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARSKY, JARED | 2 | 50.2% | +23.0% |
| LI, BAO Q | 1 | 75.9% | +26.2% |
| NESTOR, DONNA MICHELLE | 1 | 57.5% | +43.9% |
| COPPINS, JANET L | 1 | 73.4% | +25.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18621631 | CHIMERIC VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTIGEN-SPECIFIC REDIRECTORS OF IMMUNE RESPONSES | LI, BAO Q | 149d overdue |
| 17385734 | COLCHICINE SALICYLATE DERIVATIVES AND METHODS OF TREATMENT | BARSKY, JARED | 28d overdue |
| 18367416 | SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME | BARSKY, JARED | 14d |
| 17308153 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC CONDITIONS | COPPINS, JANET L | 19d |
| 18534576 | USE OF COLCHICINE TO INHIBIT TUMOR GROWTH AND METASTASES | NESTOR, DONNA MICHELLE | 34d |
| Client (Assignee) | Pending OAs |
|---|---|
| Murray Sporting Goods | 4 |
| VERIMMUNE INC. | 1 |
| Art Unit | Apps |
|---|---|
| 1628 | 3 |
| 1671 | 1 |
| 1627 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18621631 | CHIMERIC VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTIGEN-SPECIFIC REDIRECTORS OF IMMUNE RESPONSES | VERIMMUNE INC. | LI, BAO Q | 1671 | §103 | Final Rejection | 149d overdue | Pending | Mar 29, 2024 |
| 18534576 | USE OF COLCHICINE TO INHIBIT TUMOR GROWTH AND METASTASES | Murray And Poole Enterprises, Ltd. | NESTOR, DONNA MICHELLE | 1627 | §103 | Non-Final OA | 34d | Pending | Dec 09, 2023 |
| 18367416 | SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME | Murray And Poole Enterprises Ltd. | BARSKY, JARED | 1628 | §103 | Final Rejection | 14d | Pending | Sep 12, 2023 |
| 17385734 | COLCHICINE SALICYLATE DERIVATIVES AND METHODS OF TREATMENT | Murray And Poole Enterprises, Ltd. | BARSKY, JARED | 1628 | Other | Non-Final OA | 28d overdue | Pending | Jul 26, 2021 |
| 17308153 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC CONDITIONS | Murray And Poole Enterprises Ltd. | COPPINS, JANET L | 1628 | §103 | Final Rejection | 19d | Pending | May 05, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial